Skip to content
Ceratinocytes_EB House lab

External funding opportunities

On this page, EB-ResNet provides information on external funding possibilities. We do not intend to give a complete overview of funding possibilities but display interesting calls and information about other funding sources relevant for persons involved in EB research.

 

Upcoming and current external calls

 

INNOVATIVE MEDICINES INITIATIVE: IMI-2 - Call 23

Topic 5: Shortening the path to rare disease diagnosis by using newborn genetic screening and digital technologies 

Deadlines

Stage 1 submission deadline: 29 September 2020

Stage 2 submission deadline: 17 March 2021

More Information

Visit the IMI2 – Call 23 Website.

Watch the recording of the Webinar.

 

Use the „Partner Search“ Tool on the EC Funding & Tenders Website in order to find an existing consortium looking for partners and/or to offer your expertise by adding a small abstract of your institute and expertise!

 

More Information

FFG - Austrian Research Promotion Agency

Dr. Astrid Hoebertz: astrid.hoebertz@ffg.at

 

FIRTZ THYSSEN FOUNDATION: Support of Research in Medicine and Natural Sciences

The Fritz Thyssen Foundation supports research in Medicine and Natural Sciences that have a clear connection to the German research system. This connection can be established either

  • at a personal level through German scientists working on the project
  • at an institutional level through non-German scientists being affiliated to German research institutes
  • or through studies on topics related thematically to German research interests

1. Support of Projects

Deadline 15th February 2021

2. Support for Conferences

Deadline 30th November 2020

3. Postdoc Stipends

Submission anytime

4. Travel Subsidies

Submission anytime

Application

Applications may be submitted in German or in English by mail and e-mail.

Contact

Petra Kehde

Phone: +49.221.277496-184

petra.kehde@fritz-thyssen-stiftung.de

 

ALMIRALL SHARE: Collaboration Opportunities

1. Innovative Therapies for skin diseases

Maximising the value of your preclinical assets to find a breakthrough therapy for patients.

Deadline: 31 October 2020 

Scope

AlmirallShare is looking for partnering opportunities on new assets at advanced Research or preclinical Development stage.
The proposed asset should demonstrate a scientific rationale and therapeutic potential for treating dermatological conditions.

2. Move your ideas forward

Share your idea if it does not fit with current initiatives of AlmirallShare.

Submit proposal at any time

Eligibility and Application

Scientists affiliated to start-ups, biotechs, universities, research centres, and pharmaceutical companies all over the world. 

Create an account in AlmirallShare Innovation platform.

More information and Contact

https://sharedinnovation.almirall.com/

shared.innovation@almirall.com

Back to main navigation